Foslevodopa + foscarbidopa
- Status:
- Red
- Decision Date:
- February 2023
Comments
RED: NICE TA934 Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms. NHSE commissioned (Decision - December 2023) Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
search again